To suggest a premium was totally unrealistic.
I just don’t think many here understand the stage we are at - we are a biotech at beginning of ph2 to get this sort of capital in this macro environment - before commercialisation is extraordinary.
This may be your first biotech or perhaps you do t get the broader context.
Ann: Incannex Undertakes A$13 Million Institutional Placement, page-44
-
- There are more pages in this discussion • 197 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)